MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-TS-02-0022592
Rakshit Pharmaceuticals Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹238.14 Cr
▼ 6% YoY
Net profit · FY 2024
₹3.49 Cr
Net margin 1.5%
EBITDA · FY 2024
₹14.22 Cr
EBITDA margin 6%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹4.21 Cr
Issued & subscribed
Open charges
₹93.43 Cr
Satisfied ₹34.9 Cr
Company age
21 yrs
Est. 2005
Employees · EPFO
61
Provident fund records
About Rakshit Pharmaceuticals Limited
Data last updated:
Rakshit Pharmaceuticals Limited is a public limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 23 November 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24239TG2005PLC048151. Its GSTIN is 37AADCR1986L1ZT (Andhra Pradesh).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹4.21 Cr. It is led by directors including Palem Srinivas (Managing Director) and Anjaneya Pattabhi Rameswara Rao Chandana.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹238.14 Cr, a decline of 6% compared to the previous year. For the same year it recorded a net profit of ₹3.49 Cr (net margin 1.5%) and EBITDA of ₹14.22 Cr (EBITDA margin 6%). Revenue has declined at a compounded annual rate (CAGR) of 4% over three years.
The company has about 61 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹93.43 Cr and satisfied charges of ₹34.9 Cr on record. Court records list 19 cases involving the company, including 17 filed by the company and 2 filed against it; 4 cases are pending. The company has 11 deals on record (6 funding rounds, 5 secondary share transfers), with disclosed funding of ₹9.3 Cr; the latest was in August 2018. Its 8 peer companies in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Styrax Pharma Private Limited with revenue of ₹260.24 Cr.
Rakshit Pharmaceuticals Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0022592). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rakshitdrugspvtltd.com.
Company details
CIN U24239TG2005PLC048151
Registration Number 048151
Incorporation Date 23 November 2005
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0022592
CIN history
Rakshit Pharmaceuticals has one previous CIN (Corporate Identification Number): U24239AP2005PLC048151. The current CIN is U24239TG2005PLC048151, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2005PLC048151 | Current |
| U24239AP2005PLC048151 | Previous |
Key People
Palem Srinivas Managing Director Anjaneya Pattabhi Rameswara Rao Chandana Director Aruna Kumari Chandana Director Recognitions & Rankings of Rakshit Pharmaceuticals
Contact details
Rakshit Pharmaceuticals Limited's registered office is in Hyderabad, Telangana. Its website is rakshitdrugspvtltd.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlotno28 4th&5 Thfloors Sector III, Hudatechnoenclave Madhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, API Manufacturers
To see the full contact details of Rakshit Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Rakshit Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Rakshit Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Rakshit Pharmaceuticals Limited, buy the company report.
Financials of Rakshit Pharmaceuticals Limited
FY 2024 filings availableRakshit Pharmaceuticals Limited reported revenue of ₹238.14 Cr (down 6% YoY) for FY 2024.
Revenue · FY 2024
₹238.14 Cr ▼ 6%
Net profit · FY 2024
₹3.49 Cr margin 1.5%
EBITDA · FY 2024
₹14.22 Cr margin 6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 6%
3 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▼ 10%
3 years · compounded
▼ 21%
5 years · compounded
▼ 5%
Revenue has declined at a compounded annual rate (CAGR) of 4% over three years, including a 6% fall in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹14.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.49 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Rakshit Pharmaceuticals Limited, buy the company report.
Board of directors of Rakshit Pharmaceuticals Limited
Rakshit Pharmaceuticals has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Palem Srinivas | Managing Director | 07 Mar 2009 | 17 Years 7 Months | Current |
| Anjaneya Pattabhi Rameswara Rao Chandana Also directs: Organor Chemicals LLP, Rakshit Drugs Private Limited, Srisaichandana Api Private Limited and 5 more | Director | 23 Nov 2005 | 20 Years 10 Months | Current |
| Aruna Kumari Chandana Also directs: Rakshit Drugs Private Limited, Azico Biophore India Private Limited, Rakshit Research Centre Private Limited and 1 more | Director | 23 Nov 2005 | 20 Years 10 Months | Current |
| Veera Venkata Vara Prasad Veerni | Director | 17 Feb 2020 | 6 Years 8 Months | Current |
Peer comparison
Rakshit Pharmaceuticals Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Styrax Pharma Private Limited | ₹260.24 Cr (FY 2024) | 4.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Rakshit Drugs Private Limited | ₹256.13 Cr (FY 2024) | -3.0% | Hyderabad, Telangana, India | |||
| Shodhana Laboratories Private Limited | ₹250.16 Cr (FY 2024) | -23.0% | Hyderabad, Telangana, India | |||
| East India Pharmaceutical Works Limited | ₹249.94 Cr (FY 2024) | Kolkata, West Bengal, India | ||||
| Rakshit Pharmaceuticals Limitedthis company | ₹238.14 Cr (FY 2024) | ₹3.49 Cr | 1.5% | -6.0% | 61 | Hyderabad, Telangana, India |
| Century Pharmaceuticals Limited | ₹234.99 Cr (FY 2025) | -1.0% | Vadodara, Gujarat, India | |||
| Delta Finochem Private Limited | ₹234.28 Cr (FY 2025) | -18.0% | Nashik, Maharashtra, India | |||
| Hy-Gro Chemicals Pharmtek Private Limited | ₹233.66 Cr (FY 2025) | 9.0% | Sangareddy, Telangana, India | |||
| Dosch Pharmaceuticals Private Limited | ₹229.86 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Rakshit Pharmaceuticals Limited, buy the company report.
Auditor
Rakshit Pharmaceuticals Limited is audited by Ramanatham & Rao for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ramanatham & Rao | FY 2023 | 003924S |
Shareholding
The shareholding of Rakshit Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Rakshit Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹93.43 Cr
Satisfied charges
₹34.9 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Oct 2025 | 101182824 | Others | ₹7.26 Cr | Open | |
| 28 Dec 2015 | 10626018 | Others | ₹86.17 Cr | Open | |
| 14 Aug 2013 | 10448165 | Kotak Mahindra Bank Limited | ₹10 Lakh | Satisfied | |
| 25 Aug 2011 | 10304005 | Icici Bank Limited | ₹16.5 Cr | Satisfied | |
| 25 Aug 2011 | 10304417 | Icici Bank Limited | ₹11.1 Cr | Satisfied |
To see the full charge records of Rakshit Pharmaceuticals Limited, buy the company report.
Total charge records: 6 View all charges
Deals & funding
Rakshit Pharmaceuticals Limited has 11 deals on record (6 funding rounds, 5 secondary share transfers), with disclosed funding of ₹9.3 Cr; the latest was in August 2018.
Total deals
11
Funding rounds
6
Secondary share transfers
5
Disclosed funding
₹9.3 Cr
Deals on record (5 of 11)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2017 | Funding round | ₹1.25 Cr | Investors: Rakshit Drugs Private Limited |
| Sep 2011 | Funding round | ₹4 Cr | Investors: Rakshit Drugs Private Limited , an individual |
| Sep 2009 | Secondary share transfer | Undisclosed | Buyer: Rakshit Drugs Private Limited , an individual Seller: Revon Consultancy & Management Services Private Limited , Ramco Properties Private Limited , Bhagulvani Trading & Investments Private Limited |
| Apr 2009 | Secondary share transfer | Undisclosed | Buyer: Rakshit Drugs Private Limited , an individual Seller: 2 individuals |
| Apr 2009 | Secondary share transfer | Undisclosed | Buyer: Rakshit Drugs Private Limited , 3 individuals Seller: 2 individuals |
To see the full deal history of Rakshit Pharmaceuticals Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Rakshit Pharmaceuticals Limited has 19 court cases on record: 17 filed by Rakshit Pharmaceuticals, 2 filed against it. 4 cases are pending and 15 are disposed.
Total cases
19
Filed by the company
17
Filed against the company
2
Pending
4
Disposed
15
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 10 | 0 | 4 |
| High courts | 8 | 1 | 0 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 19)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, ANDHRAPRADESH | Writ petition | Filed by the company against Eastern Power Distribution Company of Andhra Pradesh Ltd., and 1 other | Disposed |
| District court, Hyderabad Central, Telangana | Court case (CC - NI) | Filed by the company against M/S. Morepen Laboratories Limited (Unit-V) Rep.By M.D., Shri Sushil Suri and 5 others | Disposed |
| District court, Hyderabad Central, Telangana | Criminal complaint | Filed by the company against M/S. Morepen Laboratories Limited (Unit-V) Rep.By M.D., Shri Sushil Suri and 5 others | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against M/S. Magbro Health Care Private Limited | Disposed |
| District court, Hyderabad CCC, Telangana | Civil suit | Filed by the company against R.T. Pharma | Pending |
To see the full case history of Rakshit Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Rakshit Pharmaceuticals Limited was last rated by Crisil on 28 May 2020.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 28 May 2020 |
To see the full credit ratings and regulatory alerts of Rakshit Pharmaceuticals Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Rakshit Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Rakshit Pharmaceuticals Limited has a workforce of 61 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
61
Active EPFO establishments
1
Employee growth
-1.61%
GST
Rakshit Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AADCR1986L1ZT | Andhra Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Rakshit Pharmaceuticals Limited, buy the company report.
Recent activity
Rakshit Pharmaceuticals Limited has 14 board changes on record since 2005: 4 appointments and 10 cessations. The latest: Sammeta Leela Venkata Nancharaiah ceased to be Whole-Time Director on 10 May 2022.
Charges
A charge with Others amounted to Rs. 7.26 Cr with Charge ID 101182824 was registered on 16 Oct 2025.
Charges
A charge with Others of Rs. 7.26 Cr registered on 16 Oct 2025 with Charge ID 101182824 was modified on 16 Oct 2025.
Charges
A charge with Others of Rs. 86.17 Cr registered on 28 Dec 2015 with Charge ID 10626018 was modified on 29 Jul 2025.
AGM
Rakshit Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Rakshit Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Sammeta Leela Venkata Nancharaiah ceased to be Whole-Time Director.
Ceased
Bhavani Sankar Alla ceased to be Additional Director.
Ceased
Veera Venkata Vara Prasad Veerni ceased to be Additional Director.
Appointed
Veera Venkata Vara Prasad Veerni was appointed as Director.
Charges
A charge registered on 14 Aug 2013 via Charge ID 10448165 with Kotak Mahindra Bank Limited was fully satisfied on 31 Jan 2017.
Charges
A charge registered on 25 Aug 2011 via Charge ID 10304005 with Icici Bank Limited was fully satisfied on 24 Feb 2016.
Charges
A charge with Others amounted to Rs. 86.17 Cr with Charge ID 10626018 was registered on 28 Dec 2015.
19 earlier events are in the company report.
Frequently asked questions
Rakshit Pharmaceuticals is an active public limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 23 November 2005 (21+ years old) and is registered under CIN U24239TG2005PLC048151.
Rakshit Pharmaceuticals has 4 current directors:
- Palem Srinivas - Managing Director
- Anjaneya Pattabhi Rameswara Rao Chandana - Director
- Aruna Kumari Chandana - Director
- Veera Venkata Vara Prasad Veerni - Director
The latest financial statements of Rakshit Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Rakshit Pharmaceuticals is 37AADCR1986L1ZT, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Rakshit Pharmaceuticals is U24239TG2005PLC048151. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Rakshit Pharmaceuticals has 19 court cases on record: 17 filed by the company and 2 filed against it. 4 are pending. Most are in the district courts.
Rakshit Pharmaceuticals was incorporated on 23 November 2005, making it 21+ years old. It is registered with the Registrar of Companies, Hyderabad.
Rakshit Pharmaceuticals has 11 deals on record (6 funding rounds, 5 secondary share transfers), with disclosed funding of ₹9.3 Cr; the latest was in August 2018.
The peers of Rakshit Pharmaceuticals by revenue are Styrax Pharma Private Limited, Rakshit Drugs Private Limited, Shodhana Laboratories Private Limited, East India Pharmaceutical Works Limited, Century Pharmaceuticals Limited and 3 more, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Sammeta Leela Venkata Nancharaiah ceased to be Whole-Time Director on 10 May 2022. Bhavani Sankar Alla ceased to be Additional Director on 31 Dec 2020. Veera Venkata Vara Prasad Veerni ceased to be Additional Director on 31 Dec 2020. Rakshit Pharmaceuticals has 14 board changes on record in total.
Yes, Rakshit Pharmaceuticals is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0022592).